Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Northwest Biotherapeutics Inc (NWBO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.497 -0.013    -2.49%
13:15:00 - Delayed Data. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 1,013,996
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.495 - 0.520
Northwest Biotherapeutics 0.497 -0.013 -2.49%

NWBO Income Statement

 
Featured here, the Income Statement (earnings report) for Northwest Biotherapeutics Inc, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Revenue 0.445 0.406 0.201 0.88
Revenue 0.445 0.406 0.201 0.88
Other Revenue, Total - - - -
Cost of Revenue, Total 7.45 7.2 6.21 6.86
Gross Profit -7.01 -6.8 -6.01 -5.98
Total Operating Expenses 15.59 14.23 13.78 13.84
Selling/General/Admin. Expenses, Total 8.13 7.03 7.56 6.98
Research & Development 7.45 7.2 6.21 6.86
Depreciation / Amortization -0.001 0.016 -0.35 0.335
Interest Expense (Income) - Net Operating -1.24 -1.67 -1.3 -1.03
Unusual Expense (Income) - - - -
Other Operating Expenses, Total -6.21 -5.55 -4.56 -6.17
Operating Income -15.14 -13.82 -13.58 -12.96
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - - - -
Other, Net 3.78 4.76 0.871 -2.31
Net Income Before Taxes -18.92 -18.58 -14.45 -10.65
Provision for Income Taxes - - - -
Net Income After Taxes -18.92 -18.58 -14.45 -10.65
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items -18.92 -18.58 -14.45 -10.65
Total Extraordinary Items - - - -
Net Income -18.92 -18.58 -14.45 -10.65
Total Adjustments to Net Income -0.341 -0.519 -0.519 -0.395
Income Available to Common Excluding Extraordinary Items -19.26 -19.1 -14.97 -11.05
Dilution Adjustment 3.99 4.11 -3.36 0.097
Diluted Net Income -22.91 -22.69 -11.08 -10.75
Diluted Weighted Average Shares 1158.43 1134.36 1108.42 1074.9
Diluted EPS Excluding Extraordinary Items -0.02 -0.02 -0.014 -0.01
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS -0.009 -0.009 -0.008 -0.005
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NWBO Comments

Write your thoughts about Northwest Biotherapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Thomas Cutler
Thomas Cutler May 09, 2023 5:23PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
FDA approval coming
Vincent
Vincent May 09, 2023 5:23PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
When?
Thomas Cutler
Thomas Cutler May 09, 2023 5:23PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
these bozos here cannot approve my link I tried to send you, but the V.P. of Walgreens said later this year possibly.
Oktay Yilmaz
Oktay Yilmaz Mar 07, 2023 2:32PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
sokayım
Oktay Yilmaz
Oktay Yilmaz Dec 05, 2022 10:26AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
go go up
Tomer Harpaz
Tomer Harpaz Sep 28, 2022 3:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Target price 20$
Rollin Herold
Rollin Herold May 02, 2022 10:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is this it? Is NWBO finally gathering momentum?
Harry Skip Robinson
SkipRob Apr 22, 2022 4:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
For everyone person selling there is one person buying, so the short term fluctuations are either manipulative or based on an indiviiduals cash flow requirements because anyone selling now, must really need the money.
Harry Skip Robinson
SkipRob Apr 21, 2022 10:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I'm still very positve on this stock. Recent price increases are justifiable. I think some good news is just slowly getting out, so as to not breach insider trading regs. Purely specualtive but this company has a lot going for it and have made enough signficant advancements to show the ethical intent to grow the company. I just bought more shares as did my research partner.
Harry Skip Robinson
SkipRob Feb 21, 2022 12:03PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The company has a compassionate use approval.
Harry Skip Robinson
SkipRob Feb 21, 2022 12:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Northwest Biotherapeutics Announces Commencement Of Cancer Vaccine Production At Its Sawston, UK Facility
Harry Skip Robinson
SkipRob Feb 11, 2022 11:17AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Many people think either an aquisition or joint venture will occur. It's takes a lot of courage and moneytary support to go something with this much potential on their own. Anybody heard any credable rumors?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email